Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US7704993B2 · kind B2 · utility
19Cited by
41References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2004 |
| Grant date | Apr 27, 2010 |
| Priority date | — |
| Expiry date | Feb 18, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D223/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.